These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 7655019)
1. Expression of bcl-xL can confer a multidrug resistance phenotype. Minn AJ; Rudin CM; Boise LH; Thompson CB Blood; 1995 Sep; 86(5):1903-10. PubMed ID: 7655019 [TBL] [Abstract][Full Text] [Related]
2. Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Dole MG; Jasty R; Cooper MJ; Thompson CB; Nuñez G; Castle VP Cancer Res; 1995 Jun; 55(12):2576-82. PubMed ID: 7780971 [TBL] [Abstract][Full Text] [Related]
3. Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells. Huang Y; Ibrado AM; Reed JC; Bullock G; Ray S; Tang C; Bhalla K Leukemia; 1997 Feb; 11(2):253-7. PubMed ID: 9009089 [TBL] [Abstract][Full Text] [Related]
4. Bcl-2 and Bcl-XL can differentially block chemotherapy-induced cell death. Simonian PL; Grillot DA; Nuñez G Blood; 1997 Aug; 90(3):1208-16. PubMed ID: 9242554 [TBL] [Abstract][Full Text] [Related]
5. Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression. Kern MA; Helmbach H; Artuc M; Karmann D; Jurgovsky K; Schadendorf D Anticancer Res; 1997; 17(6D):4359-70. PubMed ID: 9494534 [TBL] [Abstract][Full Text] [Related]
6. Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines. Nuessler V; Stötzer O; Gullis E; Pelka-Fleischer R; Pogrebniak A; Gieseler F; Wilmanns W Leukemia; 1999 Nov; 13(11):1864-72. PubMed ID: 10557064 [TBL] [Abstract][Full Text] [Related]
7. Bcl-2, Bcl-XL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death. Huang DC; Cory S; Strasser A Oncogene; 1997 Jan; 14(4):405-14. PubMed ID: 9053837 [TBL] [Abstract][Full Text] [Related]
8. Alteration of the Bcl-2/Bax status of head and neck cancer cell lines by chemotherapeutic agents. Kawakami K; Tsukuda M; Mizuno H; Nishimura G; Ishii A; Hamajima K Anticancer Res; 1999; 19(5B):3927-32. PubMed ID: 10628333 [TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells. Walczak H; Bouchon A; Stahl H; Krammer PH Cancer Res; 2000 Jun; 60(11):3051-7. PubMed ID: 10850456 [TBL] [Abstract][Full Text] [Related]
10. Down-regulation of apoptosis-related bcl-2 but not bcl-xL or bax proteins in multidrug-resistant MCF-7/Adr human breast cancer cells. Ogretmen B; Safa AR Int J Cancer; 1996 Sep; 67(5):608-14. PubMed ID: 8782646 [TBL] [Abstract][Full Text] [Related]
11. Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Decaudin D; Geley S; Hirsch T; Castedo M; Marchetti P; Macho A; Kofler R; Kroemer G Cancer Res; 1997 Jan; 57(1):62-7. PubMed ID: 8988042 [TBL] [Abstract][Full Text] [Related]
12. Expression of Bcl-xL and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage. Minn AJ; Boise LH; Thompson CB Genes Dev; 1996 Oct; 10(20):2621-31. PubMed ID: 8895663 [TBL] [Abstract][Full Text] [Related]
13. Bax can antagonize Bcl-XL during etoposide and cisplatin-induced cell death independently of its heterodimerization with Bcl-XL. Simonian PL; Grillot DA; Merino R; Nuñez G J Biol Chem; 1996 Sep; 271(37):22764-72. PubMed ID: 8798452 [TBL] [Abstract][Full Text] [Related]
14. BAX enhances paclitaxel-induced apoptosis through a p53-independent pathway. Strobel T; Swanson L; Korsmeyer S; Cannistra SA Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14094-9. PubMed ID: 8943066 [TBL] [Abstract][Full Text] [Related]
15. Distinct apoptotic responses imparted by c-myc and max. Nesbit CE; Fan S; Zhang H; Prochownik EV Blood; 1998 Aug; 92(3):1003-10. PubMed ID: 9680370 [TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance modulators PSC 833 and CsA show differential capacity to induce apoptosis in lymphoid leukemia cell lines independently of their MDR phenotype. Lopes EC; Garcia M; Benavides F; Shen J; Conti CJ; Alvarez E; Hajos SE Leuk Res; 2003 May; 27(5):413-23. PubMed ID: 12620293 [TBL] [Abstract][Full Text] [Related]
17. Bcl-xL inhibits different apoptotic pathways in rat PC12 cells. Lindenboim L; Haviv R; Stein R Neurosci Lett; 1998 Aug; 253(1):37-40. PubMed ID: 9754799 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of Bcl-XS sensitizes MCF-7 cells to chemotherapy-induced apoptosis. Sumantran VN; Ealovega MW; Nuñez G; Clarke MF; Wicha MS Cancer Res; 1995 Jun; 55(12):2507-10. PubMed ID: 7780958 [TBL] [Abstract][Full Text] [Related]
19. Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel. Wang Z; Goulet R; Stanton KJ; Sadaria M; Nakshatri H Anticancer Res; 2005; 25(3c):2367-79. PubMed ID: 16080463 [TBL] [Abstract][Full Text] [Related]
20. Overcoming of multidrug resistance by introducing the apoptosis gene, bcl-Xs, into MRP-overexpressing drug resistant cells. Ohi Y; Kim R; Toge T Int J Oncol; 2000 May; 16(5):959-69. PubMed ID: 10762632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]